BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8402501)

  • 1. Combined determination of N-myc oncogene amplification and DNA ploidy in neuroblastoma. Complementary prognostic indicators.
    Muraji T; Okamoto E; Fujimoto J; Suita S; Nakagawara A
    Cancer; 1993 Nov; 72(9):2763-8. PubMed ID: 8402501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.
    Bourhis J; Dominici C; McDowell H; Raschella G; Wilson G; Castello MA; Plouvier E; Lemerle J; Riou G; Bénard J
    J Clin Oncol; 1991 Aug; 9(8):1371-5. PubMed ID: 2072140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
    Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD
    Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.
    Look AT; Hayes FA; Shuster JJ; Douglass EC; Castleberry RP; Bowman LC; Smith EI; Brodeur GM
    J Clin Oncol; 1991 Apr; 9(4):581-91. PubMed ID: 2066755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oncogen N-myc expression and measurement of DNA ploidy in neuroblastoma: a double staining flow cytometric analysis].
    Chassevent A; Bénard J
    Bull Cancer; 1997 Mar; 84(3):29-34. PubMed ID: 9207866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
    Bourhis J; De Vathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; McNally NJ; Lemerle J; Riou G; Bénard J
    Cancer Res; 1991 Jan; 51(1):33-6. PubMed ID: 1988094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unfavorable DNA ploidy and Ha-ras p21 findings in neuroblastomas detected through mass screening.
    Kusafuka T; Nagahara N; Oue T; Imura K; Nakamura T; Kobayashi Y; Komoto Y; Fukuzawa M; Okada A; Nakayama M
    Cancer; 1995 Aug; 76(4):695-9. PubMed ID: 8625168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective study of prognostic value of DNA ploidy and proliferative activity in neuroblastoma.
    Huddart SN; Muir KR; Parkes SE; Mann JR; Stevens MC; Raafat F; Smith K
    J Clin Pathol; 1993 Dec; 46(12):1101-4. PubMed ID: 8282832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors in neuroblastoma. Usefulness of DNA analysis using flow cytometry on paraffin-embedded material].
    Massara FM; Tonello M; Forni M; Fruttero A; Lantermo R; Pugno F; Cordero di Montezemolo L; Ruà S
    Pediatr Med Chir; 1996; 18(2):141-8. PubMed ID: 8767575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative analysis of nuclear DNA content and N-myc gene amplification in neuroblastoma.
    Taylor SR; Locker J
    Cancer; 1990 Mar; 65(6):1360-6. PubMed ID: 2306684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
    Bowman LC; Castleberry RP; Cantor A; Joshi V; Cohn SL; Smith EI; Yu A; Brodeur GM; Hayes FA; Look AT
    J Natl Cancer Inst; 1997 Mar; 89(5):373-80. PubMed ID: 9060959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy in neuroblastoma.
    Eckschlager T; Pilát D; Kodet R; Dahbiová R; Stanková J; Jasinská J; Hrusák O
    Neoplasma; 1996; 43(1):23-6. PubMed ID: 8843955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of fluorescence in situ hybridization to detect N-myc (MYCN) gene amplification on paraffin-embedded tissue sections of neuroblastomas.
    Hachitanda Y; Saito M; Mori T; Hamazaki M
    Med Pediatr Oncol; 1997 Aug; 29(2):135-8. PubMed ID: 9180916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
    Bourhis J; Bénard J; DeVathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; Lemerle J; Riou G
    Prog Clin Biol Res; 1991; 366():107-13. PubMed ID: 2068130
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of N-myc amplification with neuroblastoma: the Australian and New Zealand experience.
    Telford DJ; Kavallaris M; White L; Norris MD; Brian MJ; Stewart BW
    J Paediatr Child Health; 1992 Feb; 28(1):58-63. PubMed ID: 1554517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-myc oncogene amplification and cytometric DNA ploidy pattern as prognostic factors in musculoskeletal neoplasms.
    Barrios C; Castresana JS; Falkmer UG; Rosendahl I; Kreicbergs A
    Int J Cancer; 1994 Sep; 58(6):781-6. PubMed ID: 7927868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of DNA ploidy for neuroblastoma.
    Nakazawa M
    Surg Today; 1993; 23(3):215-9. PubMed ID: 8467172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ploidy independence of Ag-NOR number in neuroblastoma.
    Brookes CN; Ooms BC; McGill F; England K; Hinchliffe SA; van Velzen D
    Lab Invest; 1992 Aug; 67(2):243-5. PubMed ID: 1501449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA content heterogeneity in neuroblastoma analyzed by means of image cytometry and its potential significance.
    Melegh Z; Csernák E; Tóth E; Veleczki Z; Magyarosy E; Nagy K; Szentirmay Z
    Virchows Arch; 2005 May; 446(5):517-24. PubMed ID: 15827757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
    Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.